Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SYNACT PHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 34459975
Dronninggårds Alle 136, 2840
Holte
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2012 · 14 years old
7 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
SYNACT PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-7M
-15M
-22M
-30M
-43M
2021
-47M
2022
-63M
2023
-26M
2024
-53M
2025
EBITDA
DKK millions
0M
-22M
-44M
-66M
-88M
-46M
2021
-54M
-17%
2022
-70M
-30%
2023
-35M
+50%
2024
-63M
-80%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-43.430
-46.951
-63.448
-26.275
-53.195
Staff expenses
-2.647
-7.454
-6.410
-8.310
-10.141
EBITDA
-46.077
-54.405
-69.858
-34.585
-63.336
Depreciation & amort.
-472
-817
-1.011
-1.449
-1.887
EBIT
-46.550
-55.222
-70.869
-36.035
-65.223
Net financials
-109
-58
-40
57
-90
Profit before tax
-46.658
-55.280
-70.909
-35.977
-65.313
Tax
-5.502
-5.500
-5.500
-5.500
-5.500
Net profit
-41.157
-49.780
-65.409
-30.477
-59.813
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
13.544
37.947
26.785
37.792
32.004
Equity
6.649
33.995
15.586
25.109
20.296
Long-term debt
0
0
0
0
0
Short-term debt
6.895
3.852
7.172
11.327
10.476
Total debt
6.895
3.852
7.172
11.327
10.476
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-6333587200.0%
This company
2021
2025
Soliditetsgrad
63.4%
This company
38.2%
Market median
+66% vs market
2021
2025
Egenkapitalforrentning
-294.7%
This company
18.4%
Market median
-1702% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-5981293700.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
-1.66×
This company
2021
2025
Gæld/egenkapital
0.58×
This company
0.62×
Market median
+6% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on SYNACT PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
